These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8848820

  • 1. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Bauer LA, Horn JR, Pettit H.
    Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F, Yukawa E, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y.
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of coadministration of verapamil and quinidine on serum digoxin concentration.
    Doering W.
    Eur J Clin Pharmacol; 1983 Jul; 25(4):517-21. PubMed ID: 6653647
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.
    Hedman A, Meijer DK.
    J Pharm Sci; 1998 Apr; 87(4):457-61. PubMed ID: 9548899
    [Abstract] [Full Text] [Related]

  • 9. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.
    Koren G, Woodland C, Ito S.
    Vet Hum Toxicol; 1998 Feb; 40(1):45-6. PubMed ID: 9467211
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.
    Innes GD, Vertesi L, Dillon EC, Metcalfe C.
    Ann Emerg Med; 1997 Jan; 29(1):126-34. PubMed ID: 8998091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.
    Koren G, MacLeod SM.
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):3-18. PubMed ID: 6473899
    [Abstract] [Full Text] [Related]

  • 13. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs.
    Belz GG, Doering W, Munkes R, Matthews J.
    Clin Pharmacol Ther; 1983 Apr; 33(4):410-7. PubMed ID: 6831819
    [Abstract] [Full Text] [Related]

  • 14. Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.
    Neuhoff S, Yeo KR, Barter Z, Jamei M, Turner DB, Rostami-Hodjegan A.
    J Pharm Sci; 2013 Sep; 102(9):3161-73. PubMed ID: 23686764
    [Abstract] [Full Text] [Related]

  • 15. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
    Woodland C, Ito S, Koren G.
    Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current status of cardiac glycoside drug interactions.
    Hooymans PM, Merkus FW.
    Clin Pharm; 1985 Apr; 4(4):404-13. PubMed ID: 2412751
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.